Category Archives: U.S. Policy and Funding

Study finds “no significant differences” in survival rates of Ebola patients getting intravenous fluids and those who didn’t

By on .

Unmeasured factors leave questions, authors note A study retrospectively examining the role of intravenous fluids in preventing deaths of Ebola patients during the 2013-2016 West Africa Ebola crisis concludes the intervention, in itself, did not make a significant difference in chances of surviving during the 28 days following diagnosis. Differences in survival rates during the […]